Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy

Abstract

In patients with severe, nonischemic dilated cardiomyopathy who were treated with ACE inhibitors and beta-blockers, the implantation of a cardioverter-defibrillator significantly reduced the risk of sudden death from arrhythmia and was associated with a nonsignificant reduction in the risk of death from any cause.